EP3090744
PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2014EP published:
24.11.2021EP application number:
14876904.5
EPO information:
European Patent Register
Max expiry date:
22.12.2034
Title in English:
PHARMACEUTICAL COMPLEX FORMULATION COMPRISING ANGIOTENSIN II RECEPTOR BLOCKER AND HMG-COA REDUCTASE INHIBITORLanguage of the patent:
English
Timeline
Today
23.12.2014EP application
24.11.2021EP Publication
Owner
Name:
Alvogen Korea Co., Ltd.Address:
13 Fl., 10, Gukjegeumyung-ro Yeongdeungpo-gu, Seoul 07326, KR
Inventor
Name:
LEE, Jae WonAddress:
Seoul 156-786, KR
Name:
PARK, Cheol WonAddress:
Seoul 120-762, KR
Name:
JUN, HunAddress:
Yongin-si Gyeonggi-do 448-525, KR
Name:
LEE, Tae WonAddress:
Suwon-si Gyeonggi-do 443-811, KR
Name:
KIM, Nam HyuckAddress:
Seoul 137-793, KR
Name:
LEE, Sun YoungAddress:
Suwon-si Gyeonggi-do 442-816, KR
Name:
YU, Ji HyuckAddress:
Seoul 122-735, KR
Priority
Number:
20130167406Date:
30.12.2013Country:
KR
Classification
Categories:
A61P 9/12, A61K 31/505, A61K 31/4184, A61K 9/20